A breakthrough approach in hematologic diseases reported that using G-CSF to mobilize HSCs and hematopoietic stem cell progenitors (CD34+) from the bone marrow of the donor allows infusion of more CD34+ cells. Here, CD34 is linked to hematologic disorder.